PS

Preeti Singh

Active Director Director DIN 11091080
DIN 11091080 First appointment May 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value •••• Premium profile

About Preeti Singh

Data last updated:

Preeti Singh is a Director at Newworld Pharmaceuticals Private Limited (since 2025). The company operates in Pharma. Newworld Pharmaceuticals Private Limited reported revenue of ₹26.5 Lakh (FY 2025).

DIN 11091080
Primary Designation Director
Industry Pharma
First Appointment 08 May 2025
Oldest Company Age 9 yrs
Largest company Newworld Pharmaceuticals Private Limited · ₹26.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 May 20252017₹26.5 Lakh (FY 2025)Active

Board colleagues of Preeti Singh

Directorship timeline

Open interactive timeline →
Newworld Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Preeti Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Preeti Singh

Preeti Singh currently holds 1 directorship: Newworld Pharmaceuticals Private Limited (Director, since 08 May 2025, revenue ₹26.5 Lakh (FY 2025)).

Preeti Singh was first appointed on 08 May 2025 as Director at Newworld Pharmaceuticals Private Limited.

The current boards of Preeti Singh's companies include Shilpi Singh (Newworld Pharmaceuticals Private Limited), Smriti (Newworld Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available